Synthetic psychoactive drugs have become a serious public health threat in recent years. This is particularly true of the fentanyls, a large family of synthetic opioids, which can be up to 10,000 times more potent than morphine. Synthetic opioids are highly addictive and, because of their potency, often prove fatal: among the roughly 72,000 drug overdose deaths in the US in 2017, some 30,000 were related to synthetic opioids.
But researchers at The Scripps Research Institute have created monoclonal antibodies–made by identical immune cells–that are effective against several synthetic opioids, including fentanyl and the deadliest of the fentanyls, carfentanil. Their findings could both combat opioid addiction as well as reduce overdose deaths.
The study looked at the efficacy of vaccines containing the newly developed opioid antibodies in animals. The team, led by Kim Janda, tested the antibodies using a common pain response challenge, in which a heated beam of light is applied to a mouse’s tail. The time it takes for the mouse to withdraw its tail is measured: quick reactions suggest the animal is feeling pain, whereas a longer response suggests that pain response has been muted.
Mice that were given opioids such as fentanyl or carfentanil without the antibody exhibited a big reduction in tail withdrawal, suggesting they could not sense the pain. When they were given the opioid-blocking antibody, tail withdrawal was normalized, suggesting that the vaccine blocked the analgesic effects of the drug.
The researchers then tested whether the vaccine could prevent against lethal overdose. In mice administered the vaccine followed by a dose of fentanyl that was fatal in non-vaccinated animals. All the vaccinated mice were protected from overdose.
The antibodies were also effective against other forms of fentanyl, including carfentanil and seven other analogs, in both pain tests and lethality studies.
Janda’s team has begun to develop human antibodies to synthetic opioids, and will test their efficacy in the future. “When it comes to the very powerful opioid carfentanil the current treatment for this opioid’s induced lethality does not work very well–it has no staying power,” says Janda. “Antibodies persist longer, and thus have enormous promise for addressing both opioid addiction as well as overdose.”
A synthetic opioid vaccine might also be used as a prophylactic measure to protect people at risk of coming into contact with the drugs, such as first responders, who have occasionally overdosed by inhaling tiny quantities of fentanyl. “These antibodies could be used to protect police, EMTs, and other first responders from inadvertent acute fentanyl exposure,” says Janda. “A canine version might even one day be used to protect drug-sniffing dogs.”
Learn more: Vaccine could help address the opioid epidemic
The Latest on: Opioid epidemic
via Google News
The Latest on: Opioid epidemic
- Colorado health officials, attorneys discuss next steps in addressing opioid epidemicon September 6, 2019 at 5:29 pm
DENVER — States and cities across the country have been lining up to hold big pharmaceutical companies and their executives accountable for the nation’s opioid epidemic that has led to thousands of ...
- MI getting federal grants to fight opioid epidemicon September 6, 2019 at 3:45 pm
GRAND RAPIDS, Mich. (WOOD) — In the way only a mother can, Theresa Adkison is still grieving for her son. “To lose my child, that’s a pain I’ve never known,” she said. On Jan. 8, 2018, Adkison said ...
- No, Parents Aren't to Blame for the Teen Opioid Epidemicon September 6, 2019 at 9:27 am
Elise Schiller remembers her daughter, Giana Natali, as smart, beautiful, and loving. She was a standout athlete who swam on scholarship at Rutgers University and worked as a vet nurse because she ...
- Kentucky hospitals sue drugmakers, distributors and retailers for opioid epidemic costson September 6, 2019 at 8:12 am
A group of 23 Kentucky hospitals is suing major drugmakers, distributors and retailers for their role in the opioid epidemic just days after a group of Texas hospitals unveiled a similar suit. The ...
- The Political Economy of the Opioid Epidemicon September 6, 2019 at 1:59 am
Late this October, in Ohio, a jury will begin hearing evidence against the pharmaceutical giants that have manufactured — and profited royally from — the opioid epidemic. This Ohio trial will be the ...
- States Should Look to Nurse Practitioners to Fight Against Opioid Epidemicon September 5, 2019 at 12:28 pm
Last year, approximately 72,000 Americans died from a drug overdose. More than two-thirds of those deaths were related to opioid use disorder, an epidemic that has left states struggling to make ...
- No ‘Silver Bullet’ in Stopping Opioid Epidemicon September 5, 2019 at 12:02 pm
LAS VEGAS -- In the late 1990s, U.S. providers were successfully sued for undertreating patients with pain, and the first things to come to mind when considering "opioid risks" were perhaps somnolence ...
- $2B In Federal Grants To Fight Opioid Epidemic Doled Out To ‘Communities Where Help Is Most Needed’on September 5, 2019 at 7:46 am
President Donald Trump said the funds will go to state and local governments to be used to increase medication-assisted treatment as well as mental health services. Regional news coverage reports ...
- Trump Administration Awards $1.8 Billion in Grants to Combat Opioid Epidemicon September 4, 2019 at 5:19 pm
Addiction experts are in wide agreement on the most effective way to help opioid addicts: Medication-assisted treatment. But most inpatient rehab facilities in the U.S. don’t offer this option. WSJ’s ...
via Bing News